- Exela Technologies XELA reported a preliminary third-quarter FY21 revenue decline of 8.5% year-on-year to $279.2 million, missing the consensus of $319.5 million.
- Segments: Revenue for the Information and Transaction Processing Solutions segment declined 11.1% Y/Y to $208.3 million due to lower volumes from COVID-19 and transition revenue roll-off.
- Healthcare Solutions' revenue was flat at $54 million. Legal and Loss Prevention Services revenue increased 1.3% Y/Y to $16.9 million.
- Margins: The gross margin expanded by 90 bps to 24.2%. The adjusted EBITDA margin contracted 292 bps to 13%.
- EPS loss of $(0.09) beat the consensus loss of $(0.12).
- Exela held $170.99 million in cash and equivalents. It used $73.6 million in operating cash flow during the nine months ended September 30.
- Outlook: Exela cut FY21 revenue to $1.16 billion - $1.18 billion from $1.25 billion - $1.39 billion, below the consensus of $1.25 billion.
- Outlook for Gross profit margin of 23% - 25% and Adjusted EBITDA margin of 16% - 17% unchanged.
- Price Action: XELA shares traded lower by 10.5% at $1.79 on the last check Friday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in